Seeing Is Believing
Currently, out of the existing stock ratings of Chalres Zhu - 405 which are a Buy (77.14%), 115 which are a Hold (21.9%), 5 which are a Sell (0.95%)
Analyst Chalres Zhu works at GUGGENHEIM and is covering the Healthcare sector with 38 price targets and ratings displayed on 6 stocks.
Chalres Zhu's average stock forecast success ratio is 22.22% with an average time for price targets to be met of 44 days.
Most recent stock forecast was given on MGNX, MacroGenics at 23-Nov-2022.
Analyst best performing recommendations are on ZYME (ZYMEWORKS).
The best stock recommendation documented was for ZYME (ZYMEWORKS) at 11/20/2019. The price target of $48 was fulfilled within 58 days with a profit of $9.24 (23.84%) receiving and performance score of 4.11.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
17
$4.33 (34.18%)
16
3 days ago
1/5 (20%)
$9.71 (42.69%)
6
Buy
25
$12.33 (97.32%)
26
1 months 11 days ago
0/7 (0%)
$17.25 (109.50%)
Hold
14
$1.33 (10.50%)
15
7 months 1 days ago
1/6 (16.67%)
$8.83 (43.84%)
22
Buy
30
$17.33 (136.78%)
25
1 years 3 months 26 days ago
1/3 (33.33%)
$13.32 (95.55%)
104
Buy
44
$27.94 (173.97%)
46
1 years 10 months 18 days ago
0/2 (0%)
$14.68 (50.06%)
What Year was the first public recommendation made by Chalres Zhu?